うっ血性心不全治療デバイス市場：製品別、エンドユーザー別-2025-2030年の世界予測

うっ血性心不全治療デバイス市場は、2023年に124億4,000万米ドルと評価され、2024年には134億4,000万米ドルに達すると予測され、CAGR 8.16％で成長し、2030年には215億4,000万米ドルに達すると予測されています。

うっ血性心不全（CHF）治療機器は、最適な心機能を促進することで心不全を管理する上で極めて重要です。これらの機器の必要性は、心不全の有病率の上昇、人口の高齢化、技術の進歩、心血管の健康に関する意識の高まりから生じています。用途は、除細動器、ペースメーカー、補助人工心臓などの植え込み型機器から、心臓再同期療法機器などの非侵襲的機器まで多岐にわたる。主なエンドユーザーには、病院、心臓専門クリニック、外来手術センターなどがあり、幅広いヘルスケア部門の依存関係を反映しています。市場成長に影響を与える主な要因としては、ヘルスケア支出の増加、高齢者人口の増加、心血管疾患の増加、医療技術の急速な進歩などが挙げられます。最新のビジネスチャンスは、新興市場におけるヘルスケア・インフラの拡大、遠隔モニタリングのための統合ワイヤレス技術、精度を高めるAI主導の診断ツールから生まれます。こうした機会は、最先端のソリューションに対する需要が高い市場、特に未開拓のヘルスケア・ニーズを抱える地域への参入や事業拡大が非常に有益であることを示唆しています。しかし、高額な治療費、厳しい規制要件、誤作動による機器リコールの可能性といった課題は、市場の拡大を制限する可能性があります。患者の受容性とアドヒアランスの問題は、高度な機器を扱う熟練した専門家の不足と相まって、特定地域での成長をさらに制限する可能性があります。技術革新の可能性のある分野としては、より費用対効果の高い機器の開発、患者の快適性とアドヒアランスの向上、AIや機械学習による治療の個別化への注力などが挙げられます。さらに、遠隔医療やモバイルヘルスアプリケーションとの接続が増えれば、患者管理が合理化され、機器の適用範囲が広がる可能性があります。うっ血性心不全治療デバイス市場は激しい競争を特徴としており、大手企業はイノベーションと戦略的パートナーシップを通じて優位性を追求しています。その結果、研究開発に投資する企業は、適応する規制とともに、この新興国市場で競争優位に立つことができます。

市場力学：急速に進化するうっ血性心不全治療デバイス市場の主要市場インサイトを公開

うっ血性心不全治療デバイス市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業組織は十分な情報に基づいた投資決定、戦略的決定の精緻化、新たなビジネスチャンスの獲得を行うことができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • ライフスタイルの変化による心不全や不整脈への感受性の高まり
  • 心臓関連疾患の早期一次診断への注目の高まり
  • 心血管疾患に対する認識を広める政府の取り組み
• 市場抑制要因
  • 比較的高価な機器と医薬品への嗜好
• 市場機会
  • CHF治療機器に対する政府承認の増加
  • CHF治療機器の技術的進歩
• 市場の課題
  • 厳しい規制当局の承認プロセス

ポーターの5つの力：うっ血性心不全治療デバイス市場をナビゲートする戦略ツール

ポーターの5つの力」フレームワークは、市場情勢の競合情勢を把握するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：うっ血性心不全治療デバイス市場における外部からの影響の把握

外部マクロ環境要因は、うっ血性心不全治療デバイス市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析うっ血性心不全治療デバイス市場における競合情勢の把握

うっ血性心不全治療デバイス市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスうっ血性心不全治療デバイス市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、うっ血性心不全治療デバイス市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨うっ血性心不全治療デバイス市場における成功への道筋を描く

うっ血性心不全治療デバイス市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • ライフスタイルの変化により心不全や不整脈に対する感受性が高まっている
    • 心臓関連疾患の早期・一次診断への重点化
    • 心血管疾患に関する意識を広める政府の取り組み
  • 抑制要因
    • 比較的高価な機器と薬剤の好み
  • 機会
    • CHF機器に対する政府承認の増加
    • CHF治療機器の技術的進歩
  • 課題
    • 厳格な規制承認プロセス
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 うっ血性心不全治療デバイス市場：製品別

• 心臓再同期療法
  • 心臓再同期療法- 除細動器
  • 心臓再同期療法- ペースメーカー
• 植込み型除細動器
  • 皮下植込み型除細動器
  • 経静脈植込み型除細動器
• ペースメーカー
• 補助人工心臓
  • 両心室補助装置
  • 左心室補助装置
  • 右心室補助装置

第7章 うっ血性心不全治療デバイス市場：エンドユーザー別

• 外来手術センター
• 病院・クリニック

第8章 南北アメリカのうっ血性心不全治療デバイス市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域のうっ血性心不全治療デバイス市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカのうっ血性心不全治療デバイス市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abiomed, Inc.
• Berlin Heart GmbH
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• HeartWare International, Inc.
• Jarvik Heart, Inc.
• LivaNova PLC
• Medtronic plc
• ReliantHeart Inc.
• St. Jude Medical, Inc.

LIST OF FIGURES

• FIGURE 1. CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET RESEARCH PROCESS
• FIGURE 2. CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET DYNAMICS
• TABLE 7. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY-DEFIBRILLATOR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY-PACEMAKER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PACEMAKER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY BIVENTRICULAR ASSIST DEVICE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY RIGHT VENTRICULAR ASSIST DEVICE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY AMBULATORY SURGERY CENTER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 36. BRAZIL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 41. CANADA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 42. CANADA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
• TABLE 43. CANADA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
• TABLE 44. CANADA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
• TABLE 45. CANADA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 46. MEXICO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 47. MEXICO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
• TABLE 48. MEXICO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 51. UNITED STATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 57. ASIA-PACIFIC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 58. ASIA-PACIFIC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
• TABLE 59. ASIA-PACIFIC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 63. AUSTRALIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 64. AUSTRALIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
• TABLE 65. AUSTRALIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
• TABLE 66. AUSTRALIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. CHINA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 69. CHINA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
• TABLE 70. CHINA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
• TABLE 71. CHINA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
• TABLE 72. CHINA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 73. INDIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 74. INDIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
• TABLE 75. INDIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
• TABLE 76. INDIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
• TABLE 77. INDIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 78. INDONESIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 79. INDONESIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
• TABLE 80. INDONESIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
• TABLE 81. INDONESIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 83. JAPAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 84. JAPAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
• TABLE 85. JAPAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
• TABLE 86. JAPAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 88. MALAYSIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 89. MALAYSIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
• TABLE 90. MALAYSIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
• TABLE 91. MALAYSIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
• TABLE 92. MALAYSIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 93. PHILIPPINES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 94. PHILIPPINES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
• TABLE 95. PHILIPPINES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
• TABLE 96. PHILIPPINES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 98. SINGAPORE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 99. SINGAPORE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
• TABLE 100. SINGAPORE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
• TABLE 101. SINGAPORE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 103. SOUTH KOREA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 104. SOUTH KOREA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
• TABLE 105. SOUTH KOREA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
• TABLE 106. SOUTH KOREA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 108. TAIWAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 109. TAIWAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
• TABLE 110. TAIWAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
• TABLE 111. TAIWAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 113. THAILAND CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 114. THAILAND CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
• TABLE 115. THAILAND CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
• TABLE 116. THAILAND CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
• TABLE 117. THAILAND CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 118. VIETNAM CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 119. VIETNAM CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
• TABLE 120. VIETNAM CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
• TABLE 121. VIETNAM CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
• TABLE 122. VIETNAM CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 123. EUROPE, MIDDLE EAST & AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 124. EUROPE, MIDDLE EAST & AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
• TABLE 125. EUROPE, MIDDLE EAST & AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
• TABLE 126. EUROPE, MIDDLE EAST & AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 129. DENMARK CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 130. DENMARK CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
• TABLE 131. DENMARK CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
• TABLE 132. DENMARK CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
• TABLE 133. DENMARK CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 134. EGYPT CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 135. EGYPT CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
• TABLE 136. EGYPT CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
• TABLE 137. EGYPT CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
• TABLE 138. EGYPT CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 139. FINLAND CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 140. FINLAND CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
• TABLE 141. FINLAND CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
• TABLE 142. FINLAND CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
• TABLE 143. FINLAND CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 144. FRANCE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 145. FRANCE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
• TABLE 146. FRANCE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
• TABLE 147. FRANCE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
• TABLE 148. FRANCE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 149. GERMANY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 150. GERMANY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
• TABLE 151. GERMANY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
• TABLE 152. GERMANY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
• TABLE 153. GERMANY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 154. ISRAEL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 155. ISRAEL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
• TABLE 156. ISRAEL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
• TABLE 157. ISRAEL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
• TABLE 158. ISRAEL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 159. ITALY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 160. ITALY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
• TABLE 161. ITALY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
• TABLE 162. ITALY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
• TABLE 163. ITALY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 164. NETHERLANDS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 165. NETHERLANDS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
• TABLE 166. NETHERLANDS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
• TABLE 167. NETHERLANDS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
• TABLE 168. NETHERLANDS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 169. NIGERIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 170. NIGERIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
• TABLE 171. NIGERIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
• TABLE 172. NIGERIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
• TABLE 173. NIGERIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 174. NORWAY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 175. NORWAY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
• TABLE 176. NORWAY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
• TABLE 177. NORWAY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
• TABLE 178. NORWAY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 179. POLAND CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 180. POLAND CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
• TABLE 181. POLAND CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
• TABLE 182. POLAND CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
• TABLE 183. POLAND CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 184. QATAR CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 185. QATAR CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
• TABLE 186. QATAR CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
• TABLE 187. QATAR CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
• TABLE 188. QATAR CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 189. RUSSIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 190. RUSSIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
• TABLE 191. RUSSIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
• TABLE 192. RUSSIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
• TABLE 193. RUSSIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 194. SAUDI ARABIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 195. SAUDI ARABIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
• TABLE 196. SAUDI ARABIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
• TABLE 197. SAUDI ARABIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
• TABLE 198. SAUDI ARABIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 199. SOUTH AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 200. SOUTH AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
• TABLE 201. SOUTH AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
• TABLE 202. SOUTH AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 204. SPAIN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 205. SPAIN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
• TABLE 206. SPAIN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
• TABLE 207. SPAIN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
• TABLE 208. SPAIN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 209. SWEDEN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 210. SWEDEN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
• TABLE 211. SWEDEN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
• TABLE 212. SWEDEN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
• TABLE 213. SWEDEN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 214. SWITZERLAND CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 215. SWITZERLAND CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
• TABLE 216. SWITZERLAND CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
• TABLE 217. SWITZERLAND CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
• TABLE 218. SWITZERLAND CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 219. TURKEY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 220. TURKEY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
• TABLE 221. TURKEY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
• TABLE 222. TURKEY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
• TABLE 223. TURKEY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 224. UNITED ARAB EMIRATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 225. UNITED ARAB EMIRATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
• TABLE 226. UNITED ARAB EMIRATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
• TABLE 227. UNITED ARAB EMIRATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 229. UNITED KINGDOM CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 230. UNITED KINGDOM CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
• TABLE 231. UNITED KINGDOM CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
• TABLE 232. UNITED KINGDOM CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 234. CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 235. CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET, FPNV POSITIONING MATRIX, 2023

The Congestive Heart Failure Treatment Device Market was valued at USD 12.44 billion in 2023, expected to reach USD 13.44 billion in 2024, and is projected to grow at a CAGR of 8.16%, to USD 21.54 billion by 2030.

Congestive heart failure (CHF) treatment devices are pivotal in managing heart failure by facilitating optimal cardiac function. The necessity of these devices arises from the rising prevalence of heart failure, an aging population, technological advancements, and increasing awareness regarding cardiovascular health. Applications range from implantable devices like defibrillators, pacemakers, and ventricular assist devices to non-invasive equipment such as cardiac resynchronization therapy devices. The primary end-users include hospitals, specialized cardiac clinics, and ambulatory surgical centers, reflecting a broad healthcare sector dependency. Key factors influencing market growth include rising healthcare expenditures, growing geriatric population, increasing incidences of cardiovascular diseases, and rapid advancements in medical technology. Latest opportunities arise from expanding healthcare infrastructure in emerging markets, integrated wireless technology for remote monitoring, and AI-driven diagnostic tools enhancing precision. These opportunities suggest entering or expanding in markets with high demand for cutting-edge solutions, particularly in regions with untapped healthcare needs, could be highly beneficial. However, challenges like high treatment costs, stringent regulatory requirements, and potential device recalls due to malfunction can limit market expansion. Acceptability and adherence issues among patients, coupled with lack of skilled professionals in handling advanced devices, can further restrict growth in certain regions. Potential innovation areas include the development of more cost-effective devices, enhancing patient comfort and adherence, and focusing on personalization of treatment via AI and machine learning. Furthermore, increasing connections with telemedicine and mobile health applications could streamline patient management and broaden device applicability. The congestive heart failure treatment device market is characterized by intense competition, with major players seeking dominance through innovations and strategic partnerships. Consequently, businesses investing in research and development, along with adaptive regulations, stand to gain a competitive edge in this evolving market landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Congestive Heart Failure Treatment Device Market

The Congestive Heart Failure Treatment Device Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing susceptibility to heart failure and arrhythmia owing to changing lifestyles
  • Increasing focus on early and primary diagnosis of heart-related disorders
  • Government initiatives spreading awareness on cardiovascular diseases
• Market Restraints
  • Relatively expensive devices and preference for drugs
• Market Opportunities
  • Rising government approvals for CHF devices
  • Technological advancements in CHF treatment devices
• Market Challenges
  • Stringent regulatory approval process

Porter's Five Forces: A Strategic Tool for Navigating the Congestive Heart Failure Treatment Device Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Congestive Heart Failure Treatment Device Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Congestive Heart Failure Treatment Device Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Congestive Heart Failure Treatment Device Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Congestive Heart Failure Treatment Device Market

A detailed market share analysis in the Congestive Heart Failure Treatment Device Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Congestive Heart Failure Treatment Device Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Congestive Heart Failure Treatment Device Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Congestive Heart Failure Treatment Device Market

A strategic analysis of the Congestive Heart Failure Treatment Device Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Congestive Heart Failure Treatment Device Market, highlighting leading vendors and their innovative profiles. These include Abiomed, Inc., Berlin Heart GmbH, Biotronik SE & Co. KG, Boston Scientific Corporation, HeartWare International, Inc., Jarvik Heart, Inc., LivaNova PLC, Medtronic plc, ReliantHeart Inc., and St. Jude Medical, Inc..

Market Segmentation & Coverage

This research report categorizes the Congestive Heart Failure Treatment Device Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Cardiac Resynchronization Therapy, Implantable Cardioverter Defibrillator, Pacemaker, and Ventricular Assist Device. The Cardiac Resynchronization Therapy is further studied across Cardiac Resynchronization Therapy-Defibrillator and Cardiac Resynchronization Therapy-Pacemaker. The Implantable Cardioverter Defibrillator is further studied across Subcutaneous Implantable Cardioverter Defibrillator and Transvenous Implantable Cardioverter Defibrillator. The Ventricular Assist Device is further studied across Biventricular Assist Device, Left Ventricular Assist Device, and Right Ventricular Assist Device.
• Based on End-User, market is studied across Ambulatory Surgery Center and Hospitals & Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing susceptibility to heart failure and arrhythmia owing to changing lifestyles
    • 5.1.1.2. Increasing focus on early and primary diagnosis of heart-related disorders
    • 5.1.1.3. Government initiatives spreading awareness on cardiovascular diseases
  • 5.1.2. Restraints
    • 5.1.2.1. Relatively expensive devices and preference for drugs
  • 5.1.3. Opportunities
    • 5.1.3.1. Rising government approvals for CHF devices
    • 5.1.3.2. Technological advancements in CHF treatment devices
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent regulatory approval process
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Congestive Heart Failure Treatment Device Market, by Product

• 6.1. Introduction
• 6.2. Cardiac Resynchronization Therapy
  • 6.2.1. Cardiac Resynchronization Therapy-Defibrillator
  • 6.2.2. Cardiac Resynchronization Therapy-Pacemaker
• 6.3. Implantable Cardioverter Defibrillator
  • 6.3.1. Subcutaneous Implantable Cardioverter Defibrillator
  • 6.3.2. Transvenous Implantable Cardioverter Defibrillator
• 6.4. Pacemaker
• 6.5. Ventricular Assist Device
  • 6.5.1. Biventricular Assist Device
  • 6.5.2. Left Ventricular Assist Device
  • 6.5.3. Right Ventricular Assist Device

7. Congestive Heart Failure Treatment Device Market, by End-User

• 7.1. Introduction
• 7.2. Ambulatory Surgery Center
• 7.3. Hospitals & Clinics

8. Americas Congestive Heart Failure Treatment Device Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Congestive Heart Failure Treatment Device Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Congestive Heart Failure Treatment Device Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abiomed, Inc.
• 2. Berlin Heart GmbH
• 3. Biotronik SE & Co. KG
• 4. Boston Scientific Corporation
• 5. HeartWare International, Inc.
• 6. Jarvik Heart, Inc.
• 7. LivaNova PLC
• 8. Medtronic plc
• 9. ReliantHeart Inc.
• 10. St. Jude Medical, Inc.